Johnson & Johnson (JNJ) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Johnson & Johnson (JNJ) PT Lowered to $135 at Stifel
April 17, 2018 5:09 PM EDTStifel lowered its price target on Johnson & Johnson (NYSE: JNJ) to $135.00 (from $145.00) while maintaining a Hold rating following better-than-expected Q1 but some operational puts and takes.
Analyst Rick Wise commented, "Overall, JNJ 1Q18 results were largely as expected with modest top-line outperformance, better-than-expected... More
